Ajjan, Ramzi A.
Battelino, Tadej http://orcid.org/0000-0002-0273-4732
Cos, Xavier
Del Prato, Stefano http://orcid.org/0000-0002-5388-0270
Philips, Jean-Christophe
Meyer, Laurent http://orcid.org/0000-0003-3687-5522
Seufert, Jochen
Seidu, Samuel http://orcid.org/0000-0002-8335-7018
Article History
Accepted: 29 February 2024
First Online: 8 April 2024
Competing interests
: R.A.A. has received institutional research grants from Abbott, Bayer, Eli Lilly and Novo Nordisk, and honoraria, education support or consulting fees from Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Menarini Pharmaceuticals, Merck Sharp & Dohme and Novo Nordisk. T.B. has received honoraria for participation on advisory boards for Novo Nordisk, Sanofi, Eli Lilly, Medtronic and Indigo Diabetes, and as a speaker for AstraZeneca, Eli Lilly, Novo Nordisk, Medtronic, Sanofi and Roche. His institution has received research grant support and travel expenses from Abbott Diabetes Care, Medtronic, Novo Nordisk, Sanofi, Sandoz and Novartis. X.C. has received speaking honoraria, consulting fees or travel support from Abbott, AstraZeneca, Boehringer Ingelheim, Lilly, Novartis, Novo Nordisk and Sanofi. X.C. is also the chair of Primary Care Diabetes Europe. S.D.P. reports grants from AstraZeneca and Boehringer Ingelheim; consulting fees from Applied Therapeutics, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Hengrui Pharmaceutical, Merck Sharpe and Dohme, Novartis Pharmaceuticals, Novo Nordisk and Sanofi; and honoraria as a speaker for AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Merck Sharpe and Dohme, Novartis Pharmaceuticals, Novo Nordisk and Sanofi. J.-C.P. reports honoraria for participation in advisory boards for Abbott. L.M. has received honoraria as a speaker for Abbott, Dexcom and participation on advisory boards for Abbott. J.S. declares consulting fees, speaker honoraria and support for attending educational meetings from Abbott. S.S. reports personal fees from Amgen, AstraZeneca, Napp Pharmaceuticals, Eli Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche, Sanofi and Boehringer Ingelheim. Additionally, S.S. reports grants from AstraZeneca, Sanofi, Servier and Janssen.